Stephanie Okey, Director at Crinetics Pharmaceuticals, Inc. (CRNX), sold 17,500 shares at $46.38 ($812K) on 2024-03-28, disclosed to the SEC on 2024-04-02.
Open-market sale of $812k CRNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-03-09 | $401K | — | Filing → |
| CRNX | SELL | 2026-03-04 | $119K | — | Filing → |
| PTCT | SELL | 2025-03-17 | $270K | — | Filing → |